Study: Cannabidiol-Based Medication Reduces Intense Seizures by 50%
Marijuana has been associated with reducing seizures in people with epilepsy for years, but only now is the topic getting more of the scientific scrutiny it deserves. In a recent study, cannabidiol (CBD) reduced the number of seizures by half in a substantial number of children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy.
GW Pharmaceuticals, a developer of cannabidiol, sponsored the study.
